Medicover Integrated Clinical Services (MICS) continues to monitor the global COVID-19 outbreak and we have an established team of experts who review our business operations on a daily basis and implement actions to keep our staff safe whole time providing the necessary services for the patients, investigators and clients who depend on us.
As the pandemic crisis evolves, COVID-19 testing for clinical studies has become urgent and critical. MICS, together with Medicover Diagnostics, offers a broad range of SARS-CoV-2 diagnostic tests, including molecular diagnostic testing as well as serological testing to diagnose as well as monitor people infected by SARS-COV-2.
Medicover Integrated Clinical Services also provides in-home and in-country customized solutions to support study sites with samples collection to keep your clinical trial on track and mitigate the possible impact of COVID-19.
Please do not hesitate to reach out to us if our COVID-19 capabilities and expertise and/or pandemic tailored clinical services could help advance your clinical development programs.
Medicover Integrated Clinical Services supports COVID-19 programs with the following assays:
SARS-CoV-2 RT-PCR Testing
- Qualitative Genetic diagnosis of virus infection SARS-CoV-2
- Quantitative determination of virus infection SARS-CoV-2 (Viral load)
SARS-CoV2 Antibody Testing
- Ab anti SARS-CoV-2 IgA quantitative ELISA
- Ab anti SARS-CoV-2 IgG quantitative ELISA
- Ab anti SARS-CoV-2 IgM chemiluminescence CLIA
- Ab anti SARS-CoV-2 IgG chemiluminescence CLIA
Medicover Integrated Clinical Services
Palio Office Park, Building A
Marynarki Polskiej 197
Write us an email.Write us
Mo-Fr, between 09:00-17:00 CET
+48 602 443 552